# RVPH (Reviva Pharmaceuticals Holdings, Inc.) - SEC EDGAR Financial Statements

> Reviva Pharmaceuticals Holdings, Inc. reported $18.56M in total assets and a net loss of $11.31M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/RVPH
- Markdown: https://convexityos.com/fundamentals/RVPH.md
- SEC CIK: 0001742927
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001742927&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$11.88M | Operating profit |
| Net Income | FY 2025 | -$11.31M | GAAP bottom line |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $17.46M | Total debt: $44K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | FY 2020 | FY 2019 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $11.71M | $22.91M | $31.42M | $22.87M | $4.85M | $4.85M | $295K | -- | $196K | -- |
| Total Operating Expenses | $20.20M | $30.80M | $39.50M | $28.23M | $10.10M | $10.10M | $2.43M | $725K | $377K | $153K |
| **Operating Income** | -$20.20M | -$30.80M | -$39.50M | -$28.23M | -$10.10M | -$10.10M | -$2.43M | -$725K | -$377K | -$153K |
| **EBITDA** | -- | -- | -- | -- | -$10.10M | -- | -$2.43M | -- | -$376K | -- |
| Interest Income | $311K | $361K | $398K | -- | -- | -- | $105K | $1.32M | $201 | $729K |
| Interest Expense | $13K | $18K | $34K | -- | -- | $0 | $1.45M | -- | $469K | -- |
| Income Before Tax | -$19.85M | -$29.90M | -$39.24M | -$28.24M | -$8.52M | -$8.52M | -$3.78M | -- | -$846K | -- |
| Income Tax Expense | $19K | $20K | $17K | $21K | $6.0K | $6.0K | $800 | $0 | $800 | -- |
| **Net Income** | -$19.86M | -$29.92M | -$39.26M | -$28.26M | -$8.52M | -$8.52M | -$3.78M | $618K | -$847K | $574K |
| Basic EPS | -$5.48 | -$17.73 | -$32.42 | -$28.49 | -$11.39 | -$11.39 | -$24.36 | -$4.13 | -$6.09 | -$0.79 |
| **Diluted EPS** | -- | -- | -- | -- | -- | -$11.39 | -$24.36 | -$4.13 | -$6.09 | -$0.79 |
| Basic Shares Outstanding | 3.6M | 1.7M | 1.2M | 993.4K | 752.9K | 752.9K | 155.8K | 132.9K | 140.9K | 103.8K |
| Diluted Shares Outstanding | -- | -- | -- | -- | -- | 752.9K | 155.8K | 132.9K | 140.9K | 103.8K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.20M | $1.39M | $1.44M | $1.74M | $2.13M | $3.72M | $4.11M | $4.68M |
| Total Operating Expenses | $2.43M | $2.62M | $3.27M | $3.56M | $4.03M | $6.07M | $6.54M | $6.28M |
| **Operating Income** | -$2.43M | -$2.62M | -$3.27M | -$3.56M | -$4.03M | -$6.07M | -$6.54M | -$6.28M |
| Interest Income | $135K | $176K | $89K | $143K | $59K | $23K | $86K | $47K |
| Interest Expense | $1.2K | $2.9K | $6.7K | -$5.6K | $2.6K | $4.8K | $12K | $4.7K |
| Income Before Tax | -$2.30M | -$2.45M | -$3.19M | -$3.36M | -$4.01M | -$6.05M | -$6.43M | -$6.25M |
| Income Tax Expense | $1.9K | $2.6K | $3.3K | $2.9K | $2.8K | $8.0K | $5.2K | $4.7K |
| **Net Income** | -$2.30M | -$2.45M | -$3.20M | -$3.37M | -$4.01M | -$6.05M | -$6.43M | -$6.26M |
| Basic EPS | -$0.17 | -$0.19 | -$0.46 | -- | -$1.09 | -$2.40 | -$2.61 | -- |
| Basic Shares Outstanding | 13.2M | 13.2M | 7.0M | -- | 3.7M | 2.5M | 2.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | FY 2019 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $14.44M | $13.48M | $23.37M | $18.52M | $29.69M | $8.76M | $69K | $193 | $313K |
| **Cash & Short-Term Investments** | $14.44M | $13.48M | $23.37M | $18.52M | $29.69M | $8.76M | $69K | $193 | $313K |
| **Total Current Assets** | $15.10M | $14.68M | $23.70M | -- | -- | -- | $139K | -- | $404K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | $0 | -- | $591 | -- |
| **Total Non-Current Assets** | $820K | $820K | $0 | -- | -- | -- | $60.88M | -- | $65.24M |
| **Total Assets** | $15.92M | $15.50M | $23.70M | $18.92M | $31.40M | $8.76M | $61.02M | $2.6K | $65.65M |
| Accounts Payable | $3.01M | $6.28M | $3.85M | $3.52M | $510K | $1.01M | $300K | $225K | $23K |
| Short-Term Debt | $407K | $458K | $0 | $0 | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $7.28M | $14.60M | $17.18M | $9.96M | $2.34M | $1.33M | $300K | -- | $23K |
| **Total Non-Current Liabilities** | $0 | $89K | $807K | $567K | $373K | $1.96M | $2.96M | -- | $2.21M |
| **Total Liabilities** | $7.28M | $14.69M | $17.98M | $10.53M | $2.72M | $3.30M | $3.26M | $6.81M | $2.24M |
| **Total Debt (incl. Leases)** | $407K | $458K | $0 | $0 | -- | -- | -- | -- | -- |
| Common Stock | $12K | $4.7K | $2.8K | $2.0K | $1.4K | $923 | $3.81M | $618 | $4.43M |
| Retained Earnings | -$184.1M | -$164.3M | -$134.4M | -$95.09M | -$66.83M | -$58.31M | $1.19M | -$54.53M | $574K |
| **Total Stockholders' Equity** | $8.65M | $813K | $5.72M | $8.39M | $28.69M | $5.47M | $5.00M | -$6.81M | $5.00M |
| Total Equity | $8.65M | $813K | $5.72M | $8.39M | $28.69M | $5.47M | $5.00M | -$6.81M | $5.00M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $17.46M | $19.89M | $22.19M | $14.44M | $13.18M | $10.36M | $5.29M | $13.48M |
| **Cash & Short-Term Investments** | $17.46M | $19.89M | $22.19M | $14.44M | $13.18M | $10.36M | $5.29M | $13.48M |
| **Total Current Assets** | $18.56M | $21.14M | $23.56M | $15.10M | $13.51M | $10.82M | $6.26M | $14.68M |
| **Total Non-Current Assets** | $0 | $0 | $0 | $820K | $820K | $820K | $820K | $820K |
| **Total Assets** | $18.56M | $21.14M | $23.56M | $15.92M | $14.33M | $11.63M | $7.08M | $15.50M |
| Accounts Payable | $2.48M | $2.46M | $2.09M | $3.01M | $5.43M | $4.97M | $4.72M | $6.28M |
| Short-Term Debt | $44K | $144K | $231K | $407K | $0 | $113K | $224K | $458K |
| **Total Current Liabilities** | $5.48M | $5.93M | $6.12M | $7.28M | $9.74M | $12.08M | $11.51M | $14.60M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $45K | $17K | $28K | $89K |
| **Total Liabilities** | $5.48M | $5.93M | $6.12M | $7.28M | $9.78M | $12.09M | $11.54M | $14.69M |
| **Total Debt (incl. Leases)** | $44K | $144K | $231K | $407K | $0 | $113K | $224K | $458K |
| Common Stock | $12K | $12K | $12K | $12K | $9.6K | $6.8K | $4.7K | $4.7K |
| Retained Earnings | -$192.1M | -$189.8M | -$187.3M | -$184.1M | -$180.8M | -$176.8M | -$170.7M | -$164.3M |
| **Total Stockholders' Equity** | $13.08M | $15.21M | $17.44M | $8.65M | $4.55M | -$459K | -$4.46M | $813K |
| Total Equity | $13.08M | $15.21M | $17.44M | $8.65M | $4.55M | -$459K | -$4.46M | $813K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | FY 2020 | FY 2019 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$19.86M | -$29.92M | -$39.26M | -$28.26M | -$8.52M | -$8.52M | -$3.78M | $618K | -$847K | $574K |
| Depreciation & Amortization | -- | -- | -- | -- | $0 | -- | $591 | -- | $645 | -- |
| Stock-Based Compensation | $2.23M | $1.63M | $3.41M | $177K | $107K | -- | $0 | -- | $0 | -- |
| Change in Payables | -$3.41M | $2.29M | $329K | $3.01M | -$498K | -- | $775K | $277K | $158K | $23K |
| **Operating Cash Flow** | -$24.59M | -$33.54M | -$28.32M | -$18.96M | -$10.67M | -- | -$4.07M | -$427K | -$218K | -$221K |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $5.70M | -- | -$64.52M |
| Common Stock Issued | -- | -- | -- | -- | $31.50M | -- | $0 | -- | -- | $25K |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -$6.27M | -- | -- |
| **Financing Cash Flow** | $25.56M | $23.65M | $33.17M | $7.79M | $31.60M | -- | $12.83M | -$5.52M | $100K | $65.05M |
| **Net Change in Cash** | $962K | -$9.89M | $4.85M | -$11.17M | $20.93M | -- | $8.76M | -$244K | -$118K | $313K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.30M | -$2.45M | -$3.20M | -$3.37M | -$4.01M | -$6.05M | -$6.43M | -$6.26M |
| Stock-Based Compensation | $171K | $215K | $584K | $455K | $458K | $395K | $919K | $554K |
| Change in Payables | $165K | $278K | -$976K | -$2.20M | $325K | $27K | -$1.56M | -$2.64M |
| **Operating Cash Flow** | -$2.18M | -$2.12M | -$3.80M | -$5.80M | -$5.59M | -$5.01M | -$8.19M | -$9.10M |
| **Financing Cash Flow** | -$247K | -$185K | $11.55M | $7.05M | $8.41M | $10.09M | $7.3K | $17.02M |
| **Net Change in Cash** | -$2.43M | -$2.30M | $7.75M | $1.26M | $2.82M | $5.07M | -$8.19M | $7.92M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | FY 2020 | FY 2019 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -229.7% | -3682.0% | -686.5% | -336.7% | -29.7% | -29.7% | -69.2% | 12.4% | -- | 11.5% |
| Return on Assets (ROA) | -124.8% | -193.0% | -165.7% | -149.3% | -27.1% | -27.1% | -43.2% | 1.0% | -32570.5% | 0.9% |
| Current Ratio | 2.08x | 1.01x | 1.38x | -- | -- | -- | -- | 0.46x | -- | 17.53x |
| Quick Ratio | 1.98x | 0.92x | 1.36x | 1.86x | 12.66x | 12.66x | 6.57x | 0.23x | -- | 13.58x |
| Debt to Equity | 0.05x | 0.56x | 0.00x | 0.00x | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | +7.6% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -86.5% | -85.6% | -95.3% | -229.7% | -500.2% | -- | -- | -3682.0% |
| Return on Assets (ROA) | -60.9% | -61.6% | -70.6% | -124.8% | -158.8% | -233.0% | -408.6% | -193.0% |
| Current Ratio | 3.39x | 3.56x | 3.85x | 2.08x | 1.39x | 0.90x | 0.54x | 1.01x |
| Quick Ratio | 3.19x | 3.35x | 3.63x | 1.98x | 1.35x | 0.86x | 0.46x | 0.92x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 0.05x | 0.00x | -- | -- | 0.56x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
